Form 4: Inovio Pharmaceuticals CFO Peter Kies Reports Stock Transactions
SEC Form 4
CFO of Inovio Pharmaceuticals, Peter Kies, reports the vesting and disposal of restricted stock units to cover tax obligations.
Summary
- Peter Kies, CFO of Inovio Pharmaceuticals, reported transactions involving common stock and restricted stock units on May 15, 2025.
- He disposed of 4,771 shares of common stock related to the vesting of restricted stock units.
- Additionally, 2,566 shares were disposed of to cover tax withholding obligations at a price of $1.95 per share.
- Following these transactions, Kies directly owns 30,257 shares of common stock and indirectly owns 375 shares through his spouse.
- He also directly owns 4,771 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in the pharmaceutical industry.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | 4,771 restricted stock units vested. |
| 05/15/2025 | Date of reported transactions: vesting of 4,771 restricted stock units and disposal of shares for tax obligations; 4,771 restricted stock units vested. |
| 05/15/2026 | 4,771 restricted stock units will vest. |
| 05/16/2025 | Date of signature for the Form 4 filing. |
Keywords
Inovio Pharmaceuticals, Peter Kies, CFO, Stock Transactions, Restricted Stock Units, Form 4, INO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.